Turkey
The disclaimer for the EAHP COVID-19 Resource Centre can be found here [175]
Links
[1] https://www.famhp.be/en/news/coronavirus_famhp_measures_to_avoid_medication_shortages
[2] https://www.afmps.be/fr/news/coronavirus_mesures_de_lafmps_pour_eviter_les_penuries_de_medicaments
[3] https://www.zorg-en-gezondheid.be/corona-richtlijnen-voor-zorgprofessionals
[4] https://www.afmps.be/fr/news/coronavirus_etat_des_stocks_de_medicaments_hospitaliers
[5] https://www.afmps.be/fr/news/coronavirus_notification_deffets_indesirables_aussi_pour_les_patients_atteints_du_covid_19
[6] https://www.afmps.be/sites/default/files/content/guidance_afmps_3d_printing.docx
[7] https://www.afmps.be/fr/news/coronavirus_lignes_directrices_pour_limpression_3d_daccessoires_dappareils_respiratoires
[8] https://www.afmps.be/fr/news/coronavirus_assouplissement_des_mesures_concernant_le_paracetamol_pour_les_pharmaciens_et_les
[9] https://www.famhp.be/en/news/coronavirus_updated_belgian_directive_for_the_reuse_of_surgical_and_ffp2ffp3_face_masks_during
[10] https://www.afmps.be/fr/news/coronavirus_mise_a_jour_de_la_directive_belge_pour_la_reutilisation_de_masques_chirurgicaux_et
[11] https://www.afmps.be/fr/news/coronavirus_hydroxychloroquine_utilisation_off_label_fortement_deconseillee_et_nouvelle_analyse
[12] https://www.afmps.be/sites/default/files/content/alternative_test_protocol_atp_masques_buccaux_v3_def_0.pdf
[13] https://www.afmps.be/fr/news/coronavirus_nouvelle_extension_des_mesures_prises_par_lafmps_pour_eviter_la_penurie_de
[14] https://www.afmps.be/fr/news/coronavirus_et_la_lutte_menee_par_lafmps_les_solutions_mises_en_place_par_lafmps_face_au_manque
[15] https://www.afmps.be/fr/news/coronavirus_lafmps_ajoute_la_dexamethasone_a_la_liste_des_medicaments_soumis_aux_mesures_de
[16] https://www.famhp.be/en/news/coronavirus_further_extension_of_the_measures_taken_by_the_famhp_to_avoid_medicinal_product_0
[17] https://www.famhp.be/en/news/influenza_vaccine_10_of_the_stocks_already_distributed_to_the_patients_two_thirds_still_to_be
[18] https://www.afmps.be/fr/news/coronavirus_questions_et_reponses_sur_les_vaccins_contre_la_covid_19
[19] http://www.notifieruneffetindesirable.be/
[20] https://www.afmps.be/fr/news/autorisations_de_fabricationdistribution_et_enregistrements_de_substances_actives_api
[21] https://www.afmps.be/fr/news/immunoglobulines_sous_cutanees_recommandations_liees_a_la_reduction_de_la_disponibilite_pour
[22] https://thl.fi/fi/web/infektiotaudit-ja-rokotukset/ajankohtaista/ajankohtaista-koronaviruksesta-covid-19
[23] https://thl.fi/en/web/infectious-diseases/what-s-new/coronavirus-covid-19-latest-updates
[24] https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=775
[25] https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=782
[26] https://www.hcsp.fr/Explore.cgi/AvisRapportsDomaine?clefr=796
[27] https://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=783
[28] https://www.ansm.sante.fr/Declarer-un-effet-indesirable/Systemes-de-vigilances-de-l-Agence/COVID-19-Dispositif-renforce-de-Pharmacovigilance-et-d-Addictovigilance/(offset)/0
[29] https://www.hcsp.fr/Explore.cgi/AvisRapportsDomaine?clefr=816
[30] https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=837
[31] https://www.hcsp.fr/Explore.cgi/AvisRapportsDomaine?clefr=854
[32] https://solidarites-sante.gouv.fr/IMG/pdf/mesures_livreurs_produits_sante.pdf
[33] https://solidarites-sante.gouv.fr/IMG/pdf/consignes_professionnels_sante_patients_handicapes_covid-19.pdf
[34] https://solidarites-sante.gouv.fr/IMG/pdf/fiche_info_pharmacienivgsuiteconsultationvf150420.pdf
[35] https://www.hcsp.fr/Explore.cgi/AvisRapportsDomaine?clefr=935
[36] https://www.hcsp.fr/Explore.cgi/AvisRapportsDomaine?clefr=951
[37] https://solidarites-sante.gouv.fr/IMG/pdf/portfolio_vaccination_anticovid_professionnels_de_sante.pdf
[38] https://www.ansm.sante.fr/Dossiers/COVID-19-Vaccins/L-ANSM-mobilisee-dans-la-mise-a-disposition-des-vaccins-COVID-19/(offset)/0
[39] https://www.ansm.sante.fr/Dossiers/COVID-19-Vaccins/Suivi-hebdomadaire-des-cas-d-effets-indesirables/(offset)/5
[40] https://splf.fr/wp-content/uploads/2020/12/HAS-Continuite-du-suivi-des-femmes-enceintes-Mise-en-ligne-le-02-04-2020-actualise-le-02-12-2020.pdf
[41] https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=978
[42] https://www.hcsp.fr/Explore.cgi/AvisRapportsDomaine?clefr=997
[43] https://ansm.sante.fr/actualites/vaccins-covid-19-lansm-publie-les-syntheses-du-comite-dexperts-sur-les-effets-thrombotiques
[44] https://ansm.sante.fr/dossiers-thematiques/covid-19-informations-de-securite/medicaments-importes-attention-au-risque-derreurs-medicamenteuses
[45] https://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=1037
[46] https://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=1048
[47] https://eody.gov.gr/neos-koronaios-covid-19/
[48] https://eody.gov.gr/covid-19-guidelines-on-home-isolation-of-suspect-cases/
[49] https://eody.gov.gr/novel-coronavirus-covid-19-advice-for-travellers/
[50] https://www.hpsc.ie/a-z/respiratory/coronavirus/novelcoronavirus/guidance/occupationalhealthguidance/Interim%20Guidance%20for%20Coronavirus%20HCW%20Mgt%20by%20Occupational%20Health.pdf
[51] https://www.hse.ie/eng/services/list/5/cancer/profinfo/safe%20reopening%20of%20cscs.pdf
[52] https://www.hse.ie/eng/services/list/5/cancer/profinfo/cd19-065-nccp-advice-on-the-management-of-patients-with-prostate-cancer.pdf
[53] https://www.hse.ie/eng/services/list/5/cancer/profinfo/cd19-122-nccp-advice-suspected-melanoma-non-melanoma.pdf
[54] https://hselibrary.ie/wp-content/uploads/2020/08/Telehealth-10.08.20-FINAL-DRAFT-00000002.pdf
[55] https://hse.drsteevenslibrary.ie/ld.php?content_id=33127678
[56] https://hse.drsteevenslibrary.ie/ld.php?content_id=33200447
[57] https://hse.drsteevenslibrary.ie/ld.php?content_id=33153324
[58] https://hse.drsteevenslibrary.ie/c.php?g=679077&p=4866802
[59] http://hselibrary.ie/wp-content/uploads/2020/05/094_Anti-Inflammatory-Medicines-for-Treatment-of-Covid-19-symptoms-For-Upload.pdf
[60] https://www.hse.ie/eng/health/immunisation/hcpinfo/covid19vaccineinfo4hps/clinicalguidance.pdf
[61] https://hse.drsteevenslibrary.ie/ld.php?content_id=33210755
[62] https://rcpi-live-cdn.s3.amazonaws.com/wp-content/uploads/2020/04/CD19-038-001_Interim-guideline-for-the-management-of-SARS-COV-2-infection-in-paediatric-patients.pdf
[63] https://hselibrary.ie/what-models-of-care-are-available-for-patients-recovering-from-covid-19-with-persisting-symptoms-what-models-of-care-are-available-for-long-covid-or-post-acute-sequelae-of-covid-19/
[64] https://www.eahp.eu/sites/default/files/regione_siciliana_-_assessorato_della_salute.pdf
[65] https://www.epicentro.iss.it/coronavirus/pdf/rapporto-covid-19-2-2020.pdf
[66] https://www.iss.it/rapporti-covid-19
[67] https://www.aifa.gov.it/documents/20142/0/idrossiclorochina1-002_01.04.2020.pdf
[68] https://www.aifa.gov.it/aggiornamento-sui-farmaci-utilizzabili-per-il-trattamento-della-malattia-covid19
[69] https://www.aifa.gov.it/raccomandazioni-sull-uso-dei-farmaci-nella-popolazione-esposta-al-virus
[70] https://www.aifa.gov.it/documents/20142/1123276/idrossiclorochina_29.05.2020.pdf/3958aea0-5a5f-2d05-b1f6-034dbe28ce2a
[71] https://www.iss.it/rapporti-covid-19/-/asset_publisher/btw1J82wtYzH/content/id/5423875?_com_liferay_asset_publisher_web_portlet_AssetPublisherPortlet_INSTANCE_btw1J82wtYzH_redirect=https%3A%2F%2Fwww.iss.it%2Frapporti-covid-19%3Fp_p_id%3Dcom_liferay_asset_publisher_web_portlet_AssetPublisherPortlet_INSTANCE_btw1J82wtYzH%26p_p_lifecycle%3D0%26p_p_state%3Dnormal%26p_p_mode%3Dview%26_com_liferay_asset_publisher_web_portlet_AssetPublisherPortlet_INSTANCE_btw1J82wtYzH_cur%3D0%26p_r_p_resetCur%3Dfalse%26_com_liferay_asset_publisher_web_portlet_AssetPublisherPortlet_INSTANCE_btw1J82wtYzH_assetEntryId%3D5423875
[72] http://www.salute.gov.it/portale/nuovocoronavirus/dettaglioContenutiNuovoCoronavirus.jsp?lingua=italiano&id=5373&area=nuovoCoronavirus&menu=vuoto
[73] https://www.iss.it/covid-19-primo-piano/-/asset_publisher/yX1afjCDBkWH/content/id/5485339?_com_liferay_asset_publisher_web_portlet_AssetPublisherPortlet_INSTANCE_yX1afjCDBkWH_redirect=https%3A%2F%2Fwww.iss.it%2Fcovid-19-primo-piano%3Fp_p_id%3Dcom_liferay_asset_publisher_web_portlet_AssetPublisherPortlet_INSTANCE_yX1afjCDBkWH%26p_p_lifecycle%3D0%26p_p_state%3Dnormal%26p_p_mode%3Dview%26_com_liferay_asset_publisher_web_portlet_AssetPublisherPortlet_INSTANCE_yX1afjCDBkWH_cur%3D0%26p_r_p_resetCur%3Dfalse%26_com_liferay_asset_publisher_web_portlet_AssetPublisherPortlet_INSTANCE_yX1afjCDBkWH_assetEntryId%3D5485339
[74] https://www.iss.it/documents/20126/0/Rapporto+ISS+COVID-19+60_2020.pdf/6b4dfc13-fc37-fadd-3388-b93aef43a15d?t=1602857089054
[75] https://www.iss.it/documents/20126/0/Rapporto+ISS+COVID-19+61_2020.pdf/c2f4f7b5-68e9-849b-0071-f36d4560d83f?t=1603878366209
[76] https://www.iss.it/rapporti-covid-19/-/asset_publisher/btw1J82wtYzH/content/id/5664933?_com_liferay_asset_publisher_web_portlet_AssetPublisherPortlet_INSTANCE_btw1J82wtYzH_redirect=https%3A%2F%2Fwww.iss.it%2Frapporti-covid-19%3Fp_p_id%3Dcom_liferay_asset_publisher_web_portlet_AssetPublisherPortlet_INSTANCE_btw1J82wtYzH%26p_p_lifecycle%3D0%26p_p_state%3Dnormal%26p_p_mode%3Dview%26_com_liferay_asset_publisher_web_portlet_AssetPublisherPortlet_INSTANCE_btw1J82wtYzH_cur%3D0%26p_r_p_resetCur%3Dfalse%26_com_liferay_asset_publisher_web_portlet_AssetPublisherPortlet_INSTANCE_btw1J82wtYzH_assetEntryId%3D5664933
[77] https://covid19.min-saude.pt/wp-content/uploads/2020/04/Folheto_EstrategiasComunicacao_V3-1.pdf
[78] https://www.infarmed.pt/web/infarmed/infarmed/-/journal_content/56/15786/3663347
[79] https://www.infarmed.pt/web/infarmed/infarmed/-/journal_content/56/15786/3624277
[80] https://covid19.min-saude.pt/dispositivos-medicos-e-equipamentos-de-protecao-individual
[81] https://covid19.min-saude.pt/wp-content/uploads/2020/03/Folheto_RecomendacoesProfissionaisSaude.pdf
[82] https://www.dgs.pt/documentos-e-publicacoes/guia-de-autocuidado-e-bem-estar-dos-profissionais-de-saude-durante-a-pandemia-pdf.aspx
[83] https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/home.htm
[84] https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos.htm
[85] https://www.aemps.gob.es/la-aemps/ultima-informacion-de-la-aemps-acerca-del-covid%E2%80%9119/tratamientos-disponibles-para-el-manejo-de-la-infeccion-respiratoria-por-sars-cov-2/
[86] https://www.aemps.gob.es/informa/notasinformativas/medicamentosusohumano-3/2020-medicamentosusohumano-3/recomendaciones-de-la-aemps-para-la-gestion-de-medicamentos-para-el-manejo-de-pacientes-con-enfermedades-en-fase-terminal-o-paliativa-en-la-situacion-sanitaria-actual/
[87] https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Listado_virucidas.pdf
[88] https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/20200404_ITCoronavirus.pdf
[89] https://www.aemps.gob.es/informa/notasinformativas/productossanitarios/2020-productossanitarios/la-aemps-informa-sobre-las-medidas-especiales-para-la-fabricacion-y-utilizacion-de-mascarillas-quirurgicas-y-batas-quirurgicas/
[90] https://www.aemps.gob.es/informa/notasinformativas/medicamentosusohumano-3/2020-medicamentosusohumano-3/medidas-excepcionales-aplicables-a-los-ensayos-clinicos-para-gestionar-los-problemas-derivados-de-la-emergencia-por-covid-19/
[91] https://www.aemps.gob.es/laAEMPS/docs/medicamentos-disponibles-SARS-CoV-2-16-4-2020.pdf?x45096
[92] https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Limpieza_y_Desinfeccion_mascarillas_higienicas_reutilizables_pdf.pdf
[93] https://www.aemps.gob.es/informa/notasinformativas/medicamentosusohumano-3/seguridad-1/2020-seguridad-1/cloroquina-hidroxicloroquina-precauciones-y-vigilancia-de-posibles-reacciones-adversas-en-pacientes-con-covid-19/
[94] https://www.aemps.gob.es/informa/notasinformativas/cosmeticoshigiene/biocidas/2020-biocidas/la-aemps-informa-sobre-las-soluciones-y-geles-hidroalcoholicos-de-desinfeccion-de-manos-con-eficacia-viricida-demostrada/
[95] https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Protocolo_manejo_clinico_uci_COVID-19.pdf
[96] https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Protocolo_manejo_clinico_ah_COVID-19.pdf
[97] https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Resumen_COVID19_AH-personas-adultas.pdf
[98] https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Resumen_COVID19_AH_pediatria_sin_tto.pdf
[99] http://www.resistenciaantibioticos.es/en/node/552
[100] https://www.aemps.gob.es/informa/notasinformativas/medicamentosusohumano-3/seguridad-1/2020-seguridad-1/medicamentos-antihipertensivos-que-actuan-sobre-el-sistema-renina-angiotensina-e-infeccion-por-covid-19/
[101] https://www.aemps.gob.es/la-aemps/ultima-informacion-de-la-aemps-acerca-del-covid%E2%80%9119/sospechas-de-reacciones-adversas-notificadas-con-tratamientos-utilizados-en-covid-19/
[102] https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/COVID19_Nota_sobre_el_uso_de_UV-C.pdf
[103] https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/COVID19_Estrategia_vigilancia_y_control_e_indicadores.pdf
[104] https://www.aemps.gob.es/la-aemps/ultima-informacion-de-la-aemps-acerca-del-covid%E2%80%9119/informacion-sobre-investigacion-clinica-sobre-la-covid-19/
[105] https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/ADAPTACION_EN_LA_UCI_DE_LAS_RECOMENDACIONES_DE_LOS_PROYECTOS_ZERO-COVID19-V1.pdf
[106] https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/Recomendaciones_estrategias_comunicacion_fatiga_pandemica.pdf
[107] https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/RECOMENDACIONES_USO_SEGURO_VACUNAS_COVID19.pdf
[108] https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/Documento_CLINICA.pdf
[109] https://www.mscbs.gob.es/profesionales/medicamentos.do
[110] https://www.bag.admin.ch/bag/fr/home/krankheiten/ausbrueche-epidemien-pandemien/aktuelle-ausbrueche-epidemien/novel-cov/information-fuer-die-aerzteschaft.html
[111] https://www.bag.admin.ch/bag/de/home/krankheiten/ausbrueche-epidemien-pandemien/aktuelle-ausbrueche-epidemien/novel-cov/information-fuer-die-aerzteschaft.html
[112] https://www.bag.admin.ch/bag/it/home/krankheiten/ausbrueche-epidemien-pandemien/aktuelle-ausbrueche-epidemien/novel-cov/information-fuer-die-aerzteschaft.html
[113] https://www.bag.admin.ch/dam/bag/fr/dokumente/mt/k-und-i/aktuelle-ausbrueche-pandemien/2019-nCoV/empfehlungen-schutzmaterial.pdf.download.pdf/Recommandations-concernant-materiel-protection.pdf
[114] https://www.swissnoso.ch/fileadmin/swissnoso/Dokumente/5_Forschung_und_Entwicklung/6_Aktuelle_Erreignisse/201029_UPDATE_Mesures_de_precautions_COVID-19_hopital_V_8.5_FR.pdf
[115] https://www.swissnoso.ch/fileadmin/swissnoso/Dokumente/5_Forschung_und_Entwicklung/6_Aktuelle_Erreignisse/201029_Vorsorgemassnahmen_COVID-19_Spital_V8.5_DE.pdf
[116] https://www.swissnoso.ch/fileadmin/swissnoso/Dokumente/5_Forschung_und_Entwicklung/6_Aktuelle_Erreignisse/200911_UPDATE_Mesures_de_precautions_COVID-19_enfants_V5.1.pdf
[117] https://www.swissnoso.ch/fileadmin/swissnoso/Dokumente/5_Forschung_und_Entwicklung/6_Aktuelle_Erreignisse/201029_Vorsorgemassnahmen_COVID-19_Spital_Paediatrie_V5.2.pdf
[118] https://www.swissnoso.ch/fileadmin/swissnoso/Dokumente/5_Forschung_und_Entwicklung/6_Aktuelle_Erreignisse/201023_management_of_COVID-19_positive_HCW_ENG_V4.1.pdf
[119] https://www.swissnoso.ch/fileadmin/swissnoso/Dokumente/5_Forschung_und_Entwicklung/6_Aktuelle_Erreignisse/210119_Interim_recommendations_acute_care_new_COVID-19_variants_v1.0_FR.pdf
[120] https://www.swissnoso.ch/fileadmin/swissnoso/Dokumente/5_Forschung_und_Entwicklung/6_Aktuelle_Erreignisse/210302_Swissnoso_Position_FFP-2_DE_v0.1.pdf
[121] https://www.swissnoso.ch/fileadmin/swissnoso/Dokumente/5_Forschung_und_Entwicklung/6_Aktuelle_Erreignisse/210329_Control_of_healthcare-associated_COVID-19_outbreaks_V2.0.pdf
[122] https://www.swissnoso.ch/fileadmin/swissnoso/Dokumente/5_Forschung_und_Entwicklung/6_Aktuelle_Erreignisse/210325_Vorsorgemassnahmen_COVID-19_Spital_V8.7_DE.pdf
[123] https://www.swissnoso.ch/fileadmin/swissnoso/Dokumente/5_Forschung_und_Entwicklung/6_Aktuelle_Erreignisse/210520_management_of_HCW_with_COVID-19_contact_V5_EN.pdf
[124] https://www.swissnoso.ch/fileadmin/swissnoso/Dokumente/5_Forschung_und_Entwicklung/6_Aktuelle_Erreignisse/210630_UPDATE_Mesures_de_precautions_COVID-19_hopital_V_9.1_FR.pdf
[125] https://lci.rivm.nl/covid-19/bijlage/medicamenteuze-behandelopties
[126] https://hsgm.saglik.gov.tr/depo/birimler/goc_sagligi/covid19/rehber/COVID-19_Rehberi20200414_eng_v4_002_14.05.2020.pdf
[127] https://hsgm.saglik.gov.tr/depo/birimler/goc_sagligi/covid19/algoritmalar/ingilizce_algoritmalar/ALGORITMA1_ENG.pdf
[128] https://hsgm.saglik.gov.tr/depo/birimler/goc_sagligi/covid19/algoritmalar/ingilizce_algoritmalar/COVID19-_Evde_Hasta_Izlemi_ENG.pdf
[129] https://hsgm.saglik.gov.tr/depo/birimler/goc_sagligi/covid19/algoritmalar/ingilizce_algoritmalar/COVID19-PLKACILHASTAYONETIMI_ENG.pdf
[130] https://hsgm.saglik.gov.tr/depo/birimler/goc_sagligi/covid19/algoritmalar/ingilizce_algoritmalar/COVID19-VAKA-SORGULAMA-KILAVUZU-A4_1_ENG.pdf
[131] https://hsgm.saglik.gov.tr/depo/birimler/goc_sagligi/covid19/algoritmalar/ingilizce_algoritmalar/COVID_TABLE_HSGM_ENG.pdf
[132] https://hsgm.saglik.gov.tr/depo/birimler/goc_sagligi/covid19/ingilizce_Formlar/01-EK-1-COVID19-TemasiOlanSaglikCalisanlarininDegerlendirilmesi-13-04-2020-ENG.pdf
[133] https://hsgm.saglik.gov.tr/depo/birimler/goc_sagligi/covid19/algoritmalar/ingilizce_algoritmalar/COVID19-TaburculukveIzolasyonKurallari-28032020.pdf_ENG.pdf
[134] https://www.nice.org.uk/guidance/ng161
[135] https://www.nice.org.uk/guidance/ng160
[136] https://www.nice.org.uk/guidance/ng162
[137] https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/877728/T1_Recommended_PPE_for_healthcare_workers_by_secondary_care_clinical_context_poster.pdf
[138] https://www.nice.org.uk/guidance/NG168
[139] https://www.nice.org.uk/guidance/NG169
[140] https://www.nice.org.uk/guidance/NG170
[141] https://www.nice.org.uk/advice/es23/chapter/Key-messages
[142] https://www.nice.org.uk/guidance/ng173
[143] https://www.nice.org.uk/guidance/ng172
[144] https://www.nice.org.uk/guidance/NG175
[145] https://www.nice.org.uk/guidance/ng174
[146] https://www.rpharms.com/Portals/0/RPS%20document%20library/Open%20access/Coronavirus/CMHP%20Monitoring%20and%20Supply%20of%20Clozapine%20during%20Covid-19%20Pandemic-RPSendorsed.pdf?ver=2020-03-31-103408-973
[147] https://www.rpharms.com/Portals/0/RPS%20document%20library/Open%20access/Coronavirus/CMHP%20Monitoring%20Lithium%20during%20Covid-19%20Pandemic-RPSendorsed.pdf?ver=2020-03-31-103408-973
[148] https://www.gov.uk/government/news/selected-nhs-patients-to-access-coronavirus-treatment-remdesivir?utm_source=6cef1529-519c-4c53-b5b4-bd1326f5f0e3&utm_medium=email&utm_campaign=govuk-notifications&utm_content=immediate
[149] https://coronavirus-yellowcard.mhra.gov.uk
[150] https://www.nice.org.uk/advice/es27/chapter/Key-messages
[151] https://www.nice.org.uk/advice/es26/chapter/Key-messages
[152] https://www.nice.org.uk/advice/es24/chapter/Key-messages
[153] https://www.nice.org.uk/advice/es25/chapter/Key-messages
[154] https://www.covid19treatmentguidelines.nih.gov/whats-new/
[155] https://www.nice.org.uk/guidance/ng161/resources/interim-treatment-change-options-during-the-covid19-pandemic-endorsed-by-nhs-england-pdf-8715724381
[156] https://www.hps.scot.nhs.uk/a-to-z-of-topics/covid-19/guidance-for-use-in-healthcare-settings/#title-container
[157] https://www.nice.org.uk/advice/mib219/chapter/Summary
[158] https://gov.wales/sites/default/files/publications/2020-06/rehabilitation-needs-of-people-affected-by-the-impact-of-covid-19_1.pdf
[159] https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/892085/disparities_review.pdf
[160] https://www.nice.org.uk/guidance/ng179
[161] https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/926410/Understanding_Cycle_Threshold__Ct__in_SARS-CoV-2_RT-PCR_.pdf
[162] https://www.nice.org.uk/guidance/ng186
[163] https://www.nice.org.uk/advice/mib219
[164] https://www.nice.org.uk/covid-19/rapid-c19
[165] https://www.gov.uk/government/groups/scientific-advisory-committee-on-nutrition
[166] https://www.england.nhs.uk/coronavirus/publication/national-guidance-for-post-covid-syndrome-assessment-clinics/
[167] https://www.nice.org.uk/guidance/ng169
[168] https://www.nice.org.uk/guidance/ng188
[169] https://www.nice.org.uk/guidance/ng187
[170] https://www.nice.org.uk/guidance/ng167
[171] https://www.nice.org.uk/Media/Default/About/COVID-19/Specialty-guides/palliative-care-in-hospital-specialty-guide.pdf
[172] https://www.nice.org.uk/sharedlearning/minimising-risks-of-covid-19-across-maternity-services
[173] https://www.nice.org.uk/sharedlearning/project-care-supporting-people-with-a-positive-diagnosis-of-covid-19-and-reaching-out-to-those-in-vulnerable-groups
[174] https://www.nice.org.uk/advice/mib264/chapter/summary
[175] https://www.eahp.eu/hp-practice/hospital-pharmacy/eahp-covid-19-resource-centre